Related Experiment Video
Updated: Dec 9, 2025

Novel Whole-tissue Quantitative Assay of Nitric Oxide Levels in Drosophila Neuroinflammatory Response
Published on: December 4, 2013
Measuring stimulation and inhibition of intracellular nitric oxide production in SIM-A9 microglia using microfluidic
Jay Sibbitts1, Christopher T Culbertson
1Department of Chemistry, Kansas State University, 1212 Mid-Campus Drive, 213 CBC Building, Manhattan, KS, USA. culbert@ksu.edu.
Abstract:
Chronic neuroinflammation has long been considered to be a central factor in accelerating the progression of neurodegenerative diseases such as Alzheimer's diseases, Parkinson's disease and chronic traumatic encephalopathy. Under pathological conditions microglia produce inflammatory signaling molecules, such as nitric oxide (NO), that can damage DNA and proteins and ultimately induce neuronal apoptosis. One strategy for treating neurodegenerative diseases is to specifically target NO production through inhibition of inducible nitric oxide synthase (iNOS). However, accurately measuring changes in microglial NO production in response to potential therapeutics is challenging due to NO's short half-life and microglial heterogeneity. In this paper we report the application of a microfluidic device for the high-throughput measurement of intracellular NO in SIM-A9 microglial cells. NO production was measured in response to treatment with lipopolysaccharides (LPS) and interferon gamma (IFN-γ) with and without a potent iNOS inhibitor (1400 W dihydrochloride). Cells were labeled with a fluorogenic NO probe, 4-amino-5-methylamino-2',7'-difluorofluoescein diacetate (DAF-FM DA), and 6-carboxyfluorescein diacetate (6-CFDA) as an internal standard. Separation and quantitation of intracellular NO was achieved using microchip electrophoresis and laser induced fluorescence detection (LIF). Statistical analysis suggests that the populations fit a lognormal distribution and are better represented by their geometric mean values. Comparison of the geometric means indicated a 1.6-fold increase in NO production between untreated and stimulated cells and a decrease by a factor of approximately 0.5 comparing stimulated and inhibited cells. Additionally, we report experimental data demonstrating the improvement in the sensitivity of our integrated optical fiber-based detection system through the use of refractive index matching gel.
Insights
This study introduces a microfluidic device for measuring nitric oxide (NO) in microglial cells, crucial for understanding neurodegenerative diseases. The device accurately quantifies NO production, aiding in the development of new therapeutic strategies.
Area of Science:
- Neuroscience
- Biochemistry
- Microfluidics
Background:
- Chronic neuroinflammation accelerates neurodegenerative diseases like Alzheimer's and Parkinson's.
- Microglia-produced nitric oxide (NO) contributes to neuronal damage and apoptosis.
- Measuring microglial NO is challenging due to its short half-life and cell heterogeneity.
Purpose of the Study:
- To develop and apply a microfluidic device for high-throughput intracellular NO measurement in microglial cells.
- To assess NO production in response to inflammatory stimuli and iNOS inhibition.
- To validate the device's sensitivity and statistical analysis methods.
Main Methods:
- Utilized a microfluidic device for SIM-A9 microglial cells.
- Measured intracellular NO using DAF-FM DA probe and 6-CFDA standard.
- Employed microchip electrophoresis and laser-induced fluorescence detection (LIF).
- Applied refractive index matching gel to enhance detection sensitivity.
Main Results:
- Demonstrated a 1.6-fold increase in NO production upon stimulation with LPS and IFN-γ.
- Showed a 0.5-fold decrease in NO production with iNOS inhibition (1400 W dihydrochloride).
- Confirmed lognormal distribution for NO production, supporting geometric mean analysis.
- Reported improved sensitivity of the optical fiber-based detection system.
Conclusions:
- The microfluidic device enables accurate, high-throughput measurement of microglial NO.
- This technology can aid in evaluating therapeutics targeting neuroinflammation and iNOS.
- The findings contribute to a better understanding of neuroinflammation in neurodegenerative disease progression.
More Related Videos
07:41Author Spotlight: Advancing Understanding Through Technological Innovations in Psychoneuroimmunology
Published on: May 31, 2024
08:32Application of Genetically Encoded Fluorescent Nitric Oxide (NO•) Probes, the geNOps, for Real-time Imaging of NO• Signals in Single Cells
Published on: March 16, 2017